Sujet(s)
Angiomatose , COVID-19 , Exanthème , Angiomatose/induit chimiquement , Vaccins contre la COVID-19 , Humains , SARS-CoV-2Sujet(s)
Cétuximab/effets indésirables , Facteur de croissance épidermique/effets indésirables , Récepteurs ErbB/antagonistes et inhibiteurs , Naevus pigmentaire/induit chimiquement , Tumeurs cutanées/induit chimiquement , Antinéoplasiques immunologiques/effets indésirables , Tumeurs colorectales/traitement médicamenteux , Humains , Mâle , Mélanome , Adulte d'âge moyenRÉSUMÉ
Around 2% of cutaneous neoplasms arise in the scalp (scalp tumours: STs). They can be classified as primary STs (epithelial, melanocytic and adnexal) or metastatic (from distal tumours or as a spreading from contiguous structures). This anatomic location is usually poorly examined during dermatological consultations, also due to the presence of the hair cover. Moreover, self-examination of the hair-covered skin is often harder for the patient. The peculiar features of the scalp may explain the worse prognosis of STs compared with neoplasms of other locations. The hair coverage protects the scalp from UV radiations, but due to the complex pathogenesis of STs, they may also develop in younger patients. Until now, STs have been not extensively investigated in the dermatological literature, and most publications are written by otolaryngologists, or by head, neck and plastic surgeons. Thus, dermatologists above all have the opportunity and the task to explore the scalp carefully, with the opportunity to make an early diagnosis, possibly changing the patient's prognosis. The aim of this paper was to review the main STs in order to increase awareness among dermatology specialists.
Sujet(s)
Tumeurs de la tête et du cou , Tumeurs cutanées , Face , Tumeurs de la tête et du cou/diagnostic , Humains , Pronostic , Cuir chevelu , Tumeurs cutanées/diagnosticSujet(s)
Carcinome épidermoïde/anatomopathologie , Dermoscopie/méthodes , Tumeurs de la vulve/anatomopathologie , Sujet âgé de 80 ans ou plus , Carcinome épidermoïde/imagerie diagnostique , Carcinome épidermoïde/ultrastructure , Femelle , Humains , Adulte d'âge moyen , Invasion tumorale/anatomopathologie , Tumeurs de la vulve/imagerie diagnostiqueRÉSUMÉ
Onychomatricoma is a rare tumour that derives from the nail matrix and grows within the nail plate. The clinical presentation can mimic many other tumours and conditions, and surgical biopsy and histopathological examination are necessary to confirm the diagnosis. As nail surgery is a painful experience for the patient and sometimes can leave permanent onychodistrophy, more precise preoperative diagnosis is needed to distinguish onychomatricoma from other nail diseases more accurately and to limit surgical interventions. The objective of this study was to evaluate current literature on imaging techniques for the diagnosis of onychomatricoma in order to understand how this technology can help the presurgical diagnosis of this tumour. We searched in the Cochrane Skin Group Specialised library, Medline, Embase and LILACS databases all studies evaluating imaging technique for the diagnosis of onychomatricoma up to February 2018. We found that not only nail dermoscopy, but also reflectance confocal microscopy, optical coherence tomography, ultrasonography and magnetic resonance can be useful in this field.
Sujet(s)
Imagerie diagnostique/méthodes , Onychopathies/imagerie diagnostique , Tumeurs cutanées/imagerie diagnostique , Dermoscopie/méthodes , Femelle , Humains , Imagerie par résonance magnétique/méthodes , Mâle , Microscopie confocale/méthodes , Onychopathies/diagnostic , Onychopathies/anatomopathologie , Maladies rares , Sensibilité et spécificité , Tumeurs cutanées/diagnostic , Tumeurs cutanées/anatomopathologie , Tomographie par cohérence optique/méthodes , Échographie-doppler/méthodesRÉSUMÉ
Mohs micrographic surgery (MMS) is a good treatment option for epithelial neoplasms, especially when localized in areas where tissue conservation is crucial, such as the nail unit (NU). MMS is a method of radical excision offering high cure rates due to the margin control and functional preservation. Our aim is to provide a review on the use of MMS for the treatment of the most common nail tumours. We revised the current literature on the use of MMS to treat malignant neoplasms (Bowen's disease, squamous cell carcinoma, melanoma, basal cell carcinoma, keratoacanthoma, carcinoma cuniculatum) and benign neoplasms (onychomatricoma and glomus tumour). MMS represents a successful surgical option for nail tumours, firstly in terms of tissue conservation: the NU anatomy is complex and the preservation of the component structures is imperative for its functionality. Secondly, due to the surgical radicality, which is essential not only for the clearing of malignant tumours, but also for benign cases, in order to reduce recurrences. Although a conservative treatment of NU melanoma with MMS has been proposed, in our experience, the conservative approach with functional surgery is a good option for the treatment of non-invasive melanoma (in situ and Ia).
Sujet(s)
Carcinome épidermoïde/chirurgie , Mélanome/chirurgie , Chirurgie de Mohs , Onychopathies/chirurgie , Tumeurs cutanées/chirurgie , Carcinome basocellulaire/chirurgie , Tumeur glomique/chirurgie , Humains , Kératoacanthome/chirurgieSujet(s)
Épithélioma in situ/diagnostic , Carcinome épidermoïde/diagnostic , Tumeurs de la vulve/diagnostic , Épithélioma in situ/anatomopathologie , Carcinome épidermoïde/anatomopathologie , Couleur , Diagnostic différentiel , Femelle , Humains , Invasion tumorale , Vulve/anatomopathologie , Tumeurs de la vulve/anatomopathologieRÉSUMÉ
Oral pigmentations (OPs) are often neglected, although a meticulous examination of the oral cavity is important not only in the diagnosis of oral melanoma, but also for the detection of important clinical findings that may indicate the presence of a systemic disease. OPs may be classified into two major groups on the basis of their clinical appearance: focal and diffuse pigmentations, even though this distinction may not appear so limpid in some cases. The former include amalgam tattoo, melanocytic nevi, melanoacanthoma and melanosis, while the latter include physiological/racial pigmentations, smoker's melanosis, drug-induced hyperpigmentations, postinflammatory hyperpigmentations and OPs associated with systemic diseases. We will discuss the most frequent OPs and the differential diagnosis with oral mucosal melanoma (OMM), underlining the most frequent lesions that need to undergo a bioptic examination and lesions that could be proposed for a sequential follow-up.